25 January 2024FeaturesBiotechnologyRebecca Lawrence

The patentability of AI-related inventions

AI has the power to revolutionise almost any industry and, without doubt, the life sciences can benefit enormously from the leaps and bounds being made in intelligent technology.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

2024 forecast: AI, patent eligibility and Fintiv

2 January 2024 Life science attorneys should see some notable developments relating to artificial intelligence, patent eligibility and the Fintiv rule, write Manita Rawat and Alexander Stein of Morgan Lewis.

Americas

French healthcare company makes $1.2bn AI drug discovery deal

18 August 2022 Partnership with San Francisco-based software biotech initially focuses on compounds for five targets | Company uses machine learning to enable structure-based drug design.

More on this story

Big Pharma

2024 forecast: AI, patent eligibility and Fintiv

Americas

French healthcare company makes $1.2bn AI drug discovery deal

18 August 2022 Partnership with San Francisco-based software biotech initially focuses on compounds for five targets | Company uses machine learning to enable structure-based drug design.

More on this story

Big Pharma

2024 forecast: AI, patent eligibility and Fintiv

Americas

French healthcare company makes $1.2bn AI drug discovery deal

18 August 2022 Partnership with San Francisco-based software biotech initially focuses on compounds for five targets | Company uses machine learning to enable structure-based drug design.